Search Results Search Sort by RelevanceMost Recent History of Medicine May 2020 What Does the Evolution From Informed Consent to Shared Decision Making Teach Us About Authority in Health Care? James F. Childress, PhD and Marcia Day Childress, PhD Reliance on disclosure rather than understanding has prompted shared decision making and represents an important cultural change in clinical practice. AMA J Ethics. 2020;22(5):E423-429. doi: 10.1001/amajethics.2020.423. Medicine and Society Jun 2016 Ethical and Epidemiological Dimensions of Labeling Psychosis Risk Cheryl M. Corcoran, MD Although the stigma of the psychosis risk label can cause harm, the label can also confer benefit and provides an explanatory framework for symptoms. AMA J Ethics. 2016;18(6):633-642. doi: 10.1001/journalofethics.2016.18.6.msoc2-1606. Art of Medicine Feb 2020 Risks, Benefits, and Conundrums of Cancer Screening Nick Love, PhD A patient’s story represents an ethical dilemma of cancer screening: it can save lives but generates diagnostic morbidity and incurs costs. AMA J Ethics. 2020;22(2):E164-165. doi: 10.1001/amajethics.2020.164. Case and Commentary Apr 2020 How Should Trainees’ Influences on Postoperative Outcomes Be Disclosed? Rhashedah Ekeoduru, MD Two pediatric cases highlight risks of prolonging anesthetic exposure for training purposes and prompt questions about influences of surgical training on outcomes. AMA J Ethics. 2020;22(4):E267-275. doi: 10.1001/amajethics.2020.267. Case and Commentary Feb 2016 Should Physicians Attempt to Persuade a Patient to Accept a Compromised Organ for Transplant? Andy A. Tully, MD, Geraldine C. Diaz, DO, and John F. Renz, MD, PhD Transplant physicians must respect indecisive patients’ autonomy while continuing to educate them during their progress towards transplantation. AMA J Ethics. 2016;18(2):101-107. doi: 10.1001/journalofethics.2017.18.2.ecas1-1602. Case and Commentary Feb 2016 How to Communicate Clearly about Brain Death and First-Person Consent to Donate Stuart J. Youngner, MD Despite clear donor consent, health professionals must communicate clearly about death to family members to avoid confusion. AMA J Ethics. 2016;18(2):108-114. doi: 10.1001/journalofethics.2017.18.2.ecas2-1602. Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
History of Medicine May 2020 What Does the Evolution From Informed Consent to Shared Decision Making Teach Us About Authority in Health Care? James F. Childress, PhD and Marcia Day Childress, PhD Reliance on disclosure rather than understanding has prompted shared decision making and represents an important cultural change in clinical practice. AMA J Ethics. 2020;22(5):E423-429. doi: 10.1001/amajethics.2020.423.
Medicine and Society Jun 2016 Ethical and Epidemiological Dimensions of Labeling Psychosis Risk Cheryl M. Corcoran, MD Although the stigma of the psychosis risk label can cause harm, the label can also confer benefit and provides an explanatory framework for symptoms. AMA J Ethics. 2016;18(6):633-642. doi: 10.1001/journalofethics.2016.18.6.msoc2-1606.
Art of Medicine Feb 2020 Risks, Benefits, and Conundrums of Cancer Screening Nick Love, PhD A patient’s story represents an ethical dilemma of cancer screening: it can save lives but generates diagnostic morbidity and incurs costs. AMA J Ethics. 2020;22(2):E164-165. doi: 10.1001/amajethics.2020.164.
Case and Commentary Apr 2020 How Should Trainees’ Influences on Postoperative Outcomes Be Disclosed? Rhashedah Ekeoduru, MD Two pediatric cases highlight risks of prolonging anesthetic exposure for training purposes and prompt questions about influences of surgical training on outcomes. AMA J Ethics. 2020;22(4):E267-275. doi: 10.1001/amajethics.2020.267.
Case and Commentary Feb 2016 Should Physicians Attempt to Persuade a Patient to Accept a Compromised Organ for Transplant? Andy A. Tully, MD, Geraldine C. Diaz, DO, and John F. Renz, MD, PhD Transplant physicians must respect indecisive patients’ autonomy while continuing to educate them during their progress towards transplantation. AMA J Ethics. 2016;18(2):101-107. doi: 10.1001/journalofethics.2017.18.2.ecas1-1602.
Case and Commentary Feb 2016 How to Communicate Clearly about Brain Death and First-Person Consent to Donate Stuart J. Youngner, MD Despite clear donor consent, health professionals must communicate clearly about death to family members to avoid confusion. AMA J Ethics. 2016;18(2):108-114. doi: 10.1001/journalofethics.2017.18.2.ecas2-1602.
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368.